To minimise disruption to its customers, Mediplus will close for an extended period during the Christmas holidays to undertake a major refurbishment and restructure of its finished-goods warehouse facility.

Final day for shipping to all customers will be Friday 19th December 2025 with the offices closing at 1pm on 24th December 2025 until 5th January 2026 at 8.30am.

May we take this opportunity to wish all of our valued customers a very happy holiday season.

POPY™ Pessaries
Product Range

Features & Benefits

The Mediplus POPY™ (Pelvic Organ Prolapse pessary) is a pioneering product designed to offer a conservative and cost-effective solution for managing pelvic organ prolapse or procidentia.

Overview

Developed as the world’s first silicone shelf pessary, the POPY™ mitigates the symptoms of prolapse and providing a comfortable, easy-to-use alternative to surgical interventions.

Conservative Management

Symptom Relief: POPY™ mitigates the impact of pelvic organ prolapse on daily activities.

Ease of Use

High-Quality Silicone: Made from 100% medical-grade silicone, the POPY™ is soft and malleable, which ensures easy fitting and removal, enhancing both patient comfort and clinician ease of use.

Reduced Risk

Soft and Gentle: The softness of the silicone reduces the risk of vaginal erosion, a common complication associated with harder pessaries, thereby improving patient safety.

Cost-Effective

Non-Surgical Solution: As a low-cost alternative to surgery, the POPY™ provides significant savings and a less invasive option for managing prolapse, making it accessible to a wider range of patients.

Innovative Design

The POPY™ range has been developed with patients’ needs at the forefront of its design.

 

Material Safety

Medical-Grade Silicone: POPY™ is crafted from 100% medical-grade silicone, ensuring it is safe for prolonged use within the body and free from harmful chemicals such as DEHP.

The Mediplus POPY™ pessary is available in various sizes to cater to individual patient needs, ensuring a perfect fit and maximum efficacy in managing pelvic organ prolapse.




    Coming soon